About Gastroenterology Associates of Pensacola, PA
Clinical Trials at Gastroenterology Associates of Pensacola, PA
During the past decade, Gastroenterology Associates of Pensacola, PA conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 3 clinical trials were completed, i.e. on
average, 30% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 3 clinical trials were completed. i.e. 60%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Gastroenterology Associates of Pensacola, PA" #1 sponsor was "Eli Lilly and Company" with 6 trials, followed by "HepQuant, LLC" with 1 trials
sponsored, "Intercept Pharmaceuticals" with 1 trials sponsored, "Takeda" with 1 trials sponsored and "Tobira Therapeutics, Inc."
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Gastroenterology Associates of Pensacola, PA"
#1 collaborator was "Nektar Therapeutics" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Gastroenterology Associates of Pensacola, PA
According to Clinical.Site data, the most researched conditions in "Gastroenterology Associates of Pensacola, PA" are
"Crohn's Disease" (3 trials), "Ulcerative Colitis" (3 trials), "Nonalcoholic Steatohepatitis" (2 trials), "Chronic Liver Disease" (1 trials) and "Colitis, Ulcerative" (1 trials). Many other conditions were trialed in "Gastroenterology Associates of Pensacola, PA" in a lesser frequency.
Clinical Trials Intervention Types at Gastroenterology Associates of Pensacola, PA
Most popular intervention types in "Gastroenterology Associates of Pensacola, PA" are "Drug" (8 trials), "Combination Product" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "Mirikizumab" (4 trials), "Blood Draw" (1 trials), "CDPATH™" (1 trials) and "Cenicriviroc" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Gastroenterology Associates of Pensacola, PA
The vast majority of trials in "Gastroenterology Associates of Pensacola, PA" are
10 trials for "All" genders.
Clinical Trials Status at Gastroenterology Associates of Pensacola, PA
Currently, there are NaN active trials in "Gastroenterology Associates of Pensacola, PA".
undefined are not yet recruiting,
4 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Gastroenterology Associates of Pensacola, PA,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Gastroenterology Associates of Pensacola, PA, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 7 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 1 trials that are defined as “Not Applicable".